
Dr Yu Chinn Joshua Chey
Grant Funded Researcher
South Australian Immunogenomics Cancer Institute
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Innate Immunity in Pancreatic Cancer
Josh is a postdoc in the Cancer and Immune Signalling Laboratory at SAiGENCI. His research surrounds the role of innate immunity in pancreatic cancer, aiming to identify validate novel biomarkers and therapeutic targets for the disease.
-
Appointments
Date Position Institution name 2024 - ongoing Postdoctoral Researcher SAiGENCI 2024 - 2024 Research Officer University of Adelaide -
Awards and Achievements
Date Type Title Institution Name Country Amount 2020 Scholarship Adelaide Graduate Research Scholarship The University of Adelaide Australia - 2018 Award Most Outstanding Student Poster: Runner Up Australia and New Zeland Society for Cell and Developmental Biology Inc. Australia - 2017 Scholarship Master of Philosophy International Scholarship 2017 The University of Adelaide Australia - 2017 Award The RA Fisher Prize for Genetics II 2016 The University of Adelaide Australia - 2015 Scholarship Adelaide Summer Research Scholarship 2015 The University of Adelaide Australia - 2014 Award Outstanding Academic Achievement Award 2014, 2015, 2016, 2017 The University of Adelaide Australia - -
Language Competencies
Language Competency English Can read, write, speak, understand spoken and peer review Malay Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2020 - 2024 University of Adelaide Australia Doctor of Philosophy 2017 - 2020 University of Adelaide, Adelaide Australia Master of Philosophy 2014 - 2017 University of Adelaide, Adelaide Australia Bachelor of Science (Biomedical Science) -
Research Interests
Biochemistry & Molecular Biology Biochemistry and Cell Biology Biological Sciences Cancer Cell Biology Cell Biology Gene and Molecular Therapy Genetics Medical and Health Sciences Innovative Therapeutics Musculoskeletal Health Translational Health Outcomes Cancer Biology and Clinical Oncology Immunology and Infection Biomarkers
-
Journals
Year Citation 2025 Chey, Y. C. J., Gierus, L., Lushington, C., Arudkumar, J. C., B Geiger, A., Staker, L. G., . . . Thomas, P. Q. (2025). Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reduction. . BMC genomics, 26(1), 138.
2024 Chey, Y. C. J., Corbett, M. A., Arudkumar, J., Piltz, S. G., Thomas, P. Q., & Adikusuma, F. (2024). CRISPR-mediated megabase-scale transgene de-duplication to generate a functional single-copy full-length humanized DMD mouse model. BMC Biology, 22(1), 15 pages.
2023 Chey, Y. C. J., Arudkumar, J., Aartsma‐Rus, A., Adikusuma, F., & Thomas, P. Q. (2023). CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies. WIREs Mechanisms of Disease, 15(1), e1580-1-e1580-26.
Scopus10 WoS4 Europe PMC92021 Adikusuma, F., Lushington, C., Arudkumar, J., Godahewa, G. I., Chey, Y. C. J., Gierus, L., . . . Thomas, P. Q. (2021). Optimized nickase- and nuclease-based prime editing in human and mouse cells. Nucleic Acids Research, 49(18), 10785-10795.
Scopus48 WoS26 Europe PMC272018 Sim, J., Cowburn, A. S., Palazon, A., Madhu, B., Tyrakis, P. A., Macias, D., . . . Johnson, R. S. (2018). The Factor Inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia. Cell Metabolism, 27(4), 898-e.7.
Scopus62 WoS45 Europe PMC38- Arudkumar, J., Chey, Y. C. J., Piltz, S. G., Thomas, P. Q., & Adikusuma, F. (n.d.). CRISPR-mediated generation and comprehensive phenotyping of Duchenne Muscular Dystrophy mouse models. BMC Methods, 1(1).
-
Theses
Year Citation 2019 Chey, Y. C. (2019). Generation and Transcriptomic Analysis of HIF-1Alpha and HIF-2Alpha Knockout 5TGM1 Multiple Myeloma Cells. (Master's Thesis). -
Preprint
Year Citation 2024 Chey, Y., Corbett, M., Arudkumar, J., Piltz, S., Thomas, P., & Adikusuma, F. (2024). Megabase-Scale Transgene De-Duplication to Generate a Functional Single-Copy Full-Length Human DMD Transgenic Mouse Model.
DOI2024 Chey, Y., Gierus, L., Lushington, C., Arudkumar, J., Geiger, A., Staker, L., . . . Adikusuma, F. (2024). Enhancing gRNA Transcript levels by Reducing the Scaffold Poly-T Tract for Optimal SpCas9- and SaCas9-mediated Gene Editing.
DOI2024 Arudkumar, J., Chey, Y. C. J., Piltz, S. G., Thomas, P. Q., & Adikusuma, F. (2024). Generation and characterisation of mouse models of Duchenne Muscular Dystrophy (DMD).
DOI2021 Adikusuma, F., Lushington, C., Arudkumar, J., Godahewa, G., Chey, Y. C. J., Gierus, L., . . . Thomas, P. (2021). Optimized nickase- and nuclease-based prime editing in human and mouse cells.
DOI
2023, 2024 - Guest Lecturer, Biochemistry III: Cancer, Stem Cells and Development
2018, 2019, 2022 - Prac Lab Demonstrator, Biochemistry III: Cancer, Stem Cells and Development
-
Committee Memberships
Date Role Committee Institution Country 2022 - 2024 Member Adelaide Protein Group Australian Society for Biochemistry and Molecular Biology Australia -
Memberships
Date Role Membership Country 2021 - 2022 Member Australian Society for Medical Research Australia 2021 - 2024 Member Australasian Gene and Cell Therapy Society Australia 2018 - 2026 Member Australia and New Zealand Society for Cell and Developmental Biology Australia 2017 - 2025 Member Australian Society for Biochemistry and Molecular Biology Australia
Connect With Me
External Profiles